Analysis of MTI-101-treated MM cells shows that MTI-101 increases intracellular Ca2+ via a release from ER stores and via Ca2+ entry through Stim1-mediated activation of TRPC1. This evidence concerns the gene TRPC1 and Miyoshi myopathy.